載入...
Imaging biomarker roadmap for cancer studies
Imaging biomarkers (IBs) are integral to the routine management of patients with cancer. IBs used daily in oncology include clinical TNM stage, objective response and left ventricular ejection fraction. Other CT, MRI, PET and ultrasonography biomarkers are used extensively in cancer research and dru...
Na minha lista:
| 發表在: | Nat Rev Clin Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5378302/ https://ncbi.nlm.nih.gov/pubmed/27725679 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrclinonc.2016.162 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|